COVID-19 pneumonia causes more damage than typical pneumonia, says study ANI | Updated: Jan 12, 2021 23:19 IST
Washington [US], January 12 (ANI): Researchers from the Northwestern University claims that COVID-19pneumonia spreads like multiple wildfires, leaving destroyed lung tissue in its wake.
COVID pneumonia is significantly different from pneumonia caused by other causes, reports a new study. The infection leaves damage in its wake and fuels the fever, low blood pressure and damage to the kidneys, brain, heart and other organs in patients with COVID-19. Scientists discovered a target for treating COVID pneumonia.
Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung over the course of hours. In the modern intensive care unit, these bacteria or viruses are usually controlled either by antibiotics or by the body s immune system within the first few days of the illness.
The virus SARS-CoV-2, which causes COVID-19.
Sanford Burnham Prebys Medical Discovery Institute
Senior study author Sumit Chanda, Ph.D., director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. Previous Next
Newswise LA JOLLA, CALIF. – Jan 12, 2020 – Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified the sensor in human lungs that detects SARS-CoV-2 and signals that it’s time to mount an antiviral response. The study, published today in
Cell Reports, provides insights into the molecular basis of severe disease and may enable new strategies for the treatment and prevention of COVID-19.
“Our research has shown that MDA-5 is the immune cop that’s tasked to keep an eye out for SARS-CoV-2 and call for back-up,” says Sumit Chanda, Ph.D., director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys and senior author of the study. “MDA-5 recognizes replicating viruses in lung cells and activate
1.
Saliva sampling could be a similarly sensitive, less costly alternative to nasal swabs for COVID-19 testing
Nasopharyngeal swabs are the primary sampling method used for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but they require a trained health care professional and extensive personal protective equipment. Saliva-based sampling for detecting SARS-CoV-2 has the potential to address many barriers associated with nasopharyngeal swabs. Authors from McGill University summarize evidence comparing the sensitivities for detection of SARS-CoV-2 infection between nasopharyngeal swabs and saliva samples. They found that saliva sampling to be a similarly sensitive and less costly alternative that could replace nasopharyngeal swabs for collection of clinical samples for SARS-CoV-2 testing.
Northwestern University — Assistant or Associate Professor, Center for Health Information Partnerships : The Journal of Blacks in Higher Education jbhe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jbhe.com Daily Mail and Mail on Sunday newspapers.
OMRON Healthcare Continues to Transform the Heart Health Marketplace with New Remote Patient Monitoring Service & Digital Health Tools at CES 2021
Global heart health leader introduces VitalSight™, its first remote patient monitoring service, and previews a new app that will increase the capabilities of every OMRON connected blood pressure monitor
News provided by
Share this article
Share this article
LAKE FOREST, Ill., Jan. 11, 2021 /PRNewswire/ OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal heart health technology, is unveiling its first remote patient monitoring service at CES 2021, along with new digital health tools to boost patient-to-physician communication and empower more active management of hypertension. With these new innovations, OMRON – which in the last three years has introduced the first wearable blood pressure monitor and the first blood pressure monitor with built-in EKG – is continuing to transform the globa